首页 | 本学科首页   官方微博 | 高级检索  
     

高三尖杉酯碱联合方案治疗高白细胞慢性粒细胞白血病疗效分析
引用本文:刘志刚. 高三尖杉酯碱联合方案治疗高白细胞慢性粒细胞白血病疗效分析[J]. 华西医学, 2010, 25(8): 1421-1422
作者姓名:刘志刚
作者单位:大竹县人民医院血液肿瘤内科,四川大竹,635100
摘    要:
目的探讨高三尖杉酯碱(HHT)联合三氧化二砷(As2O3)、羟基脲治疗高白细胞慢性粒细胞白血病(CML)的疗效和毒副作用。方法对2004年11月-2009年12月行高三尖杉酯碱联合As2O3、羟基脲治疗高白细胞CML患者21例的疗效和不良反应进行分析。结果经高三尖杉酯碱联合As2O3、羟基脲治疗后3~6个疗程,21例CML患者中完全缓解15例,占71%;部分缓解2例,占10%;总有效率81%;未缓解4例,占19%。不良反应仅表现乏力、纳差、恶心、脱发。结论 HHT联合As2O3、羟基脲是治疗高白细胞CML一种有效率高,临床容易开展,安全性好的方法。

关 键 词:白血病  髓样  慢性  联合抗肿瘤疗法

Curative Effect of Homoharringtonine United Program on Patients with Chronic Myelocytic Leukemia
LIU Zhi-gang. Curative Effect of Homoharringtonine United Program on Patients with Chronic Myelocytic Leukemia[J]. West China Medical Journal, 2010, 25(8): 1421-1422
Authors:LIU Zhi-gang
Affiliation:LIU Zhi-gang. Blood Tumor Medicine Department,People's Hospital of Dazhu,Sichuan 635100,P. R. China
Abstract:
Objective To investigate the effects and side effects of homoharringtonine combined with arsenic trioxide or hydroxycarbamide on hyperleukocytic chronic myelocytic leukemia ( CML). Methods The therapeutic effects and adverse effects of homoharringtonine combined with arsenic trioxide or hydroxycarbamide administered in 21 cases with CML from November 2004 to December 2009. Results In 21 patients with CML,the CR rate was 71% ( 15 /21) and PR rate was 10% ( 2 /21). The total respondence rate was 81% and the side effects were slight. The side effect only shows short of strength,appetite decrease,naupathia,hair loss and no heart side effect. Conclusion Homoharringtonine combined with arsenic trioxide or hydroxycabamide has a high effect rate on CML with good safety.
Keywords:Leukemia  Myelin  Chronicity  Joint antineoplastic therapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号